Stock Analysis on Net
Stock Analysis on Net

Thermo Fisher Scientific Inc. (NYSE:TMO)

$24.99

Cash Flow Statement

The cash flow statement provides information about a company cash receipts and cash payments during an accounting period, showing how these cash flows link the ending cash balance to the beginning balance shown on the company balance sheet.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

Paying user area

Try for free

Thermo Fisher Scientific Inc. pages available for free this week:

The data is hidden behind: . Unhide it.

Get access

This is a one-time payment. There is no automatic renewal.

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Thermo Fisher Scientific Inc., consolidated cash flow statement

US$ in millions

Microsoft Excel
12 months ended: Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Net income
Depreciation of property, plant and equipment
Amortization of acquisition-related intangible assets
Change in deferred income taxes
Gain on sales of businesses
Stock-based compensation
Loss on early extinguishment of debt
Other non-cash expenses
Accounts receivable
Inventories
Contract assets/liabilities
Accounts payable
Contributions to retirement plans
Other
Changes in assets and liabilities, excluding the effects of acquisitions
Adjustments to reconcile net income to net cash provided by operating activities
Net cash provided by operating activities
Acquisitions, net of cash acquired
Proceeds from sale of business, net of cash divested
Purchase of property, plant and equipment
Proceeds from sale of property, plant and equipment
Proceeds from cross-currency interest rate swap interest settlements
Other investing activities, net
Net cash used in investing activities
Net proceeds from issuance of debt
Repayment of debt
Proceeds from issuance of commercial paper
Repayments of commercial paper
Purchases of company common stock
Dividends paid
Other financing activities, net
Net cash provided by (used in) financing activities
Exchange rate effect on cash
Increase (decrease) in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at beginning of year
Cash, cash equivalents and restricted cash at end of year

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

Cash flow statement item Description The company
Net cash provided by operating activities Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. Thermo Fisher Scientific Inc. net cash provided by operating activities decreased from 2021 to 2022 and from 2022 to 2023.
Net cash used in investing activities Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. Thermo Fisher Scientific Inc. net cash used in investing activities increased from 2021 to 2022 but then slightly decreased from 2022 to 2023.
Net cash provided by (used in) financing activities Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. Thermo Fisher Scientific Inc. net cash provided by (used in) financing activities decreased from 2021 to 2022 and from 2022 to 2023.